IL-2-independent activation and proliferation in human T cells induced by CD28.

Although the role of CD28 in T cell costimulation is firmly established, the mechanisms by which it exerts its costimulatory actions are less clear. In many circumstances it is difficult to distinguish the effects of CD28 from subsequent actions of cytokines, such as IL-2, on T cell proliferation. Here, we report a model of CD28 costimulation using PMA plus the natural ligand CD80 that resulted in very limited stimulation of IL-2, as evidenced by both cytokine production and IL-2 promoter stimulation. Promoter assays revealed CD28-dependent effects on both NF-kappaB and AP-1, but not on NF-AT or the intact IL-2 promoter. In addition, T cell proliferation was completely resistant to the actions of the immunosuppressant cyclosporin A (CsA). Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2. We also investigated the effects of stimulating T cell blasts with CD80 alone and found that there was a limited requirement for IL-2 in this system. We conclude that CD28 costimulation can cause substantial T cell proliferation in the absence of IL-2, which is driven by a soluble factor independent of NF-AT transactivation.

[1]  D. Olive,et al.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling , 1994, Nature.

[2]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[3]  A. Sica,et al.  The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Andrius Kazlauskas,et al.  The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.

[5]  J. Westwick,et al.  Ligation of CD28 receptor by B7 induces formation of D‐3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation , 1993, European journal of immunology.

[6]  D. Loh,et al.  Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. , 1995, Journal of immunology.

[7]  T. Curran,et al.  The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun , 1993, Nature.

[8]  P. Linsley,et al.  CD28 Receptor Crosslinking Induces Tyrosine Phosphorylation of PLCγ1 , 1992 .

[9]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[10]  R. Lahesmaa,et al.  Activation of Nuclear Factor of Activated T Cells in a Cyclosporin A-resistant Pathway (*) , 1996, The Journal of Biological Chemistry.

[11]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[12]  H. Reiser,et al.  Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Thompson,et al.  CD28 costimulation prevents cell death during primary T cell activation. , 1996, Journal of immunology.

[14]  C Anasetti,et al.  Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 , 1993, The Journal of experimental medicine.

[15]  D. Fearon,et al.  CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation , 1995, Molecular and cellular biology.

[16]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[17]  J. Westwick,et al.  Inhibition of CD28‐mediated T cell costimulation by the phosphoinositide 3‐kinase inhibitor wortmannin , 1995, European journal of immunology.

[18]  G. Crabtree,et al.  Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression , 1996, Nature.

[19]  A. Khoruts,et al.  A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism , 1998, The Journal of experimental medicine.

[20]  P. Linsley,et al.  CD28 receptor crosslinking induces tyrosine phosphorylation of PLC gamma 1. , 1992, Advances in experimental medicine and biology.

[21]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[22]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[23]  D. Williams,et al.  Protein kinase C is not a downstream effector of p21ras in activated T cells , 1995, European journal of immunology.

[24]  P. Linsley,et al.  CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. , 1993, Journal of immunology.

[25]  G. Crabtree,et al.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.

[26]  T. Tan,et al.  CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. , 1994, The Journal of biological chemistry.

[27]  L. Walker,et al.  Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. , 1998, Journal of immunology.

[28]  D. Olive,et al.  Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling , 1994, Nature.

[29]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[30]  S. Ward,et al.  Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals. , 1996, Journal of immunology.

[31]  D. Olive,et al.  The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras , 1994, The Journal of experimental medicine.

[32]  B. Hemmings,et al.  Ligation of the T cell co‐stimulatory receptor CD28 activates the serine‐threonine protein kinase protein kinase B , 1997, European journal of immunology.

[33]  S. Pai,et al.  Cross‐linking CD28 leads to activation of 70‐kDa S6 kinase , 1994, European journal of immunology.

[34]  H. Schneider,et al.  CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. , 1998, Journal of immunology.

[35]  Masahiko Hibi,et al.  JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.

[36]  C. Thompson,et al.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression , 1987, Molecular and cellular biology.

[37]  D. Sansom,et al.  B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation. , 1993, Immunology.

[38]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[39]  T. Soderling,et al.  NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. , 1993, The Journal of biological chemistry.

[40]  J. Pober,et al.  Transcriptional Regulation of the Interleukin-2 Gene in Normal Human Peripheral Blood T Cells , 1996, The Journal of Biological Chemistry.